Asif H. Khan
- ORCID iD
-
0000-0001-9158-0116
Show
Sort by
-
- Journal Article
- A1
- open access
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP
-
Dupilumab reduces asthma disease burden and recurrent SCS use in patients with CRSwNP and coexisting asthma
-
Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial
-
Symptom free days in patients with severe chronic rhinosinusitis with nasal polyps treated with dupilumab
-
- Journal Article
- A1
- open access
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
-
- Journal Article
- A1
- open access
AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
-
Chronic rhinosinusitis : natural history, impact on health-related quality of life, and patient perspectives
(2022) -
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases
-
Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB143-AB143